| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Tubules, Proximal | 20 | 2002 | 81 | 0.750 |
Why?
|
| Wilms Tumor | 18 | 2001 | 47 | 0.720 |
Why?
|
| Kidney Neoplasms | 17 | 2002 | 206 | 0.570 |
Why?
|
| Heartburn | 1 | 2010 | 46 | 0.370 |
Why?
|
| Kidney | 15 | 2003 | 945 | 0.370 |
Why?
|
| Extracellular Space | 1 | 2010 | 121 | 0.370 |
Why?
|
| Cadmium | 5 | 1994 | 21 | 0.340 |
Why?
|
| Esophagus | 1 | 2010 | 303 | 0.330 |
Why?
|
| Gastroesophageal Reflux | 1 | 2010 | 318 | 0.310 |
Why?
|
| Cochlea | 4 | 2004 | 169 | 0.290 |
Why?
|
| Microscopy, Electron | 17 | 2003 | 351 | 0.270 |
Why?
|
| Cells, Cultured | 27 | 2004 | 2673 | 0.250 |
Why?
|
| Cystic Fibrosis | 5 | 1988 | 283 | 0.230 |
Why?
|
| Nerve Growth Factors | 3 | 1987 | 75 | 0.200 |
Why?
|
| Epithelium | 8 | 2010 | 172 | 0.190 |
Why?
|
| Freeze Fracturing | 6 | 1994 | 11 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 15 | 2002 | 852 | 0.190 |
Why?
|
| Submandibular Gland | 4 | 1988 | 34 | 0.180 |
Why?
|
| Schools, Medical | 2 | 2012 | 157 | 0.180 |
Why?
|
| Culture Techniques | 2 | 1992 | 65 | 0.180 |
Why?
|
| Ligaments | 3 | 2004 | 14 | 0.170 |
Why?
|
| Immunohistochemistry | 11 | 2003 | 1174 | 0.160 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 3 | 1989 | 7 | 0.150 |
Why?
|
| Spiral Ganglion | 1 | 1996 | 47 | 0.140 |
Why?
|
| Salivary Glands | 4 | 1990 | 52 | 0.130 |
Why?
|
| RNA, Messenger | 10 | 2002 | 1664 | 0.120 |
Why?
|
| Humans | 54 | 2012 | 68618 | 0.120 |
Why?
|
| Cations, Divalent | 1 | 1993 | 27 | 0.120 |
Why?
|
| Gestational Age | 2 | 1994 | 389 | 0.110 |
Why?
|
| Potassium Channels, Calcium-Activated | 2 | 2004 | 8 | 0.110 |
Why?
|
| Skin | 2 | 1986 | 451 | 0.110 |
Why?
|
| Animals | 27 | 2004 | 20881 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 1993 | 71 | 0.110 |
Why?
|
| School Admission Criteria | 1 | 2012 | 36 | 0.110 |
Why?
|
| Organizational Objectives | 1 | 2012 | 70 | 0.100 |
Why?
|
| Mice, Nude | 8 | 2001 | 294 | 0.100 |
Why?
|
| Cultural Diversity | 1 | 2012 | 67 | 0.100 |
Why?
|
| Phenylephrine | 3 | 1996 | 61 | 0.100 |
Why?
|
| Child, Preschool | 12 | 1999 | 3187 | 0.100 |
Why?
|
| Faculty, Medical | 1 | 2012 | 110 | 0.100 |
Why?
|
| Cell Death | 4 | 2007 | 329 | 0.100 |
Why?
|
| Neoplasm Transplantation | 7 | 1998 | 160 | 0.090 |
Why?
|
| Cell Division | 7 | 1996 | 541 | 0.090 |
Why?
|
| Minority Groups | 1 | 2012 | 197 | 0.090 |
Why?
|
| Esophageal pH Monitoring | 1 | 2010 | 27 | 0.090 |
Why?
|
| Pilocarpine | 2 | 1987 | 9 | 0.090 |
Why?
|
| Esophagoscopy | 1 | 2010 | 72 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 127 | 0.090 |
Why?
|
| Isoproterenol | 2 | 1987 | 163 | 0.090 |
Why?
|
| Male | 25 | 2012 | 37321 | 0.090 |
Why?
|
| Genes, p53 | 3 | 2001 | 41 | 0.090 |
Why?
|
| Mice | 15 | 2003 | 8474 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 1993 | 370 | 0.090 |
Why?
|
| Sweat Glands | 2 | 1987 | 10 | 0.090 |
Why?
|
| Monitoring, Ambulatory | 1 | 2010 | 84 | 0.090 |
Why?
|
| Curriculum | 2 | 2012 | 575 | 0.090 |
Why?
|
| Calcium | 5 | 2004 | 929 | 0.090 |
Why?
|
| Proton Pump Inhibitors | 1 | 2010 | 91 | 0.090 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2002 | 231 | 0.090 |
Why?
|
| Apoptosis | 3 | 2007 | 1641 | 0.090 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2010 | 171 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 7 | 2002 | 196 | 0.080 |
Why?
|
| Education, Medical | 1 | 2010 | 147 | 0.080 |
Why?
|
| Immunity, Innate | 2 | 2007 | 156 | 0.080 |
Why?
|
| Infant | 11 | 1999 | 2891 | 0.080 |
Why?
|
| Glucose | 2 | 1993 | 307 | 0.080 |
Why?
|
| Gerbillinae | 4 | 2004 | 156 | 0.080 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 5 | 1994 | 72 | 0.080 |
Why?
|
| beta-Defensins | 1 | 2007 | 8 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1140 | 0.070 |
Why?
|
| Histocytochemistry | 5 | 1993 | 149 | 0.070 |
Why?
|
| Folic Acid | 3 | 1993 | 123 | 0.070 |
Why?
|
| Cell Membrane | 5 | 1994 | 525 | 0.070 |
Why?
|
| Female | 21 | 2012 | 38074 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 1986 | 20 | 0.070 |
Why?
|
| Epithelial Cells | 5 | 2002 | 431 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 194 | 0.070 |
Why?
|
| Anaplasia | 2 | 1997 | 7 | 0.070 |
Why?
|
| Carbonic Anhydrases | 3 | 1996 | 18 | 0.060 |
Why?
|
| Cyclic AMP | 5 | 2002 | 223 | 0.060 |
Why?
|
| Antibodies, Neoplasm | 2 | 1994 | 6 | 0.060 |
Why?
|
| Gentamicins | 3 | 1994 | 68 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2004 | 34 | 0.060 |
Why?
|
| Genes, Wilms Tumor | 2 | 1993 | 5 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 4 | 1994 | 1026 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2003 | 411 | 0.060 |
Why?
|
| Xenobiotics | 1 | 2003 | 17 | 0.060 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2003 | 24 | 0.060 |
Why?
|
| Antigens | 1 | 1984 | 90 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2004 | 246 | 0.060 |
Why?
|
| Child | 9 | 1999 | 6405 | 0.060 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 81 | 0.050 |
Why?
|
| Cochlear Duct | 1 | 2003 | 5 | 0.050 |
Why?
|
| Biological Transport | 5 | 1992 | 210 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1996 | 317 | 0.050 |
Why?
|
| Ion Channel Gating | 1 | 2003 | 42 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2003 | 174 | 0.050 |
Why?
|
| Benzylidene Compounds | 1 | 2002 | 16 | 0.050 |
Why?
|
| Infant, Newborn | 6 | 2002 | 2455 | 0.050 |
Why?
|
| Growth Substances | 1 | 2002 | 77 | 0.050 |
Why?
|
| Receptors, Dopamine D1 | 2 | 2002 | 87 | 0.050 |
Why?
|
| Nephroma, Mesoblastic | 1 | 2002 | 1 | 0.050 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2002 | 8 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 63 | 0.050 |
Why?
|
| Aniline Compounds | 1 | 2002 | 52 | 0.050 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 86 | 0.050 |
Why?
|
| Mice, Inbred ICR | 3 | 1987 | 44 | 0.050 |
Why?
|
| Calpain | 1 | 2003 | 205 | 0.050 |
Why?
|
| Mitochondria | 2 | 2003 | 643 | 0.050 |
Why?
|
| Gene Expression | 3 | 2007 | 770 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Blotting, Northern | 5 | 2002 | 189 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 146 | 0.050 |
Why?
|
| Insulin-Like Growth Factor II | 3 | 1996 | 52 | 0.050 |
Why?
|
| Adult | 8 | 2010 | 21403 | 0.050 |
Why?
|
| Diabetic Nephropathies | 1 | 2003 | 161 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2007 | 778 | 0.050 |
Why?
|
| Hypertension | 2 | 2002 | 1535 | 0.050 |
Why?
|
| Chlorides | 2 | 1994 | 68 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2007 | 756 | 0.050 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2003 | 195 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2002 | 183 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 271 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 1996 | 1745 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2002 | 384 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1996 | 765 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 498 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 626 | 0.040 |
Why?
|
| ADP Ribose Transferases | 1 | 1999 | 5 | 0.040 |
Why?
|
| Transcription, Genetic | 2 | 1999 | 562 | 0.040 |
Why?
|
| Transplantation, Heterologous | 3 | 1996 | 122 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 1999 | 50 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 659 | 0.040 |
Why?
|
| Biological Transport, Active | 3 | 2003 | 49 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2002 | 627 | 0.040 |
Why?
|
| Rhabdoid Tumor | 1 | 1998 | 9 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 1997 | 1070 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2004 | 1447 | 0.040 |
Why?
|
| Membrane Potentials | 4 | 2004 | 200 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 3 | 1999 | 511 | 0.040 |
Why?
|
| Middle Aged | 6 | 2010 | 21147 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1999 | 133 | 0.040 |
Why?
|
| Electrophysiology | 4 | 1994 | 160 | 0.040 |
Why?
|
| Kidney Tubules | 2 | 2003 | 80 | 0.040 |
Why?
|
| Cell Survival | 4 | 1994 | 901 | 0.040 |
Why?
|
| Neurons | 1 | 2003 | 881 | 0.040 |
Why?
|
| Genes, MDR | 1 | 1997 | 9 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 1998 | 532 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2007 | 90 | 0.040 |
Why?
|
| RNA, Neoplasm | 2 | 1994 | 76 | 0.040 |
Why?
|
| Base Sequence | 4 | 2004 | 1015 | 0.040 |
Why?
|
| Mitotic Index | 2 | 1996 | 14 | 0.040 |
Why?
|
| Endoplasmic Reticulum, Smooth | 1 | 1996 | 3 | 0.040 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 1996 | 13 | 0.040 |
Why?
|
| Spinal Cord Injuries | 1 | 2003 | 551 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 1999 | 307 | 0.030 |
Why?
|
| Calcium-Transporting ATPases | 1 | 1996 | 40 | 0.030 |
Why?
|
| Creatine Kinase | 1 | 1996 | 46 | 0.030 |
Why?
|
| Vimentin | 1 | 1996 | 47 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 76 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 1996 | 4 | 0.030 |
Why?
|
| Suramin | 1 | 1996 | 9 | 0.030 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1996 | 13 | 0.030 |
Why?
|
| Tetrahydrofolates | 2 | 1993 | 28 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 1996 | 42 | 0.030 |
Why?
|
| Tretinoin | 1 | 1996 | 92 | 0.030 |
Why?
|
| Vasoconstriction | 1 | 1996 | 81 | 0.030 |
Why?
|
| Angiotensin II | 2 | 1996 | 220 | 0.030 |
Why?
|
| Immunochemistry | 2 | 1987 | 17 | 0.030 |
Why?
|
| Proteins | 1 | 1999 | 474 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 1999 | 597 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1996 | 308 | 0.030 |
Why?
|
| Microvilli | 2 | 1992 | 22 | 0.030 |
Why?
|
| Cytoplasm | 2 | 2003 | 155 | 0.030 |
Why?
|
| Fetus | 2 | 1993 | 157 | 0.030 |
Why?
|
| South Carolina | 2 | 2012 | 2752 | 0.030 |
Why?
|
| Culture Media, Serum-Free | 1 | 1994 | 35 | 0.030 |
Why?
|
| Metallothionein | 1 | 1994 | 20 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 1996 | 371 | 0.030 |
Why?
|
| Cadmium Chloride | 2 | 1994 | 3 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 1993 | 18 | 0.030 |
Why?
|
| Models, Biological | 5 | 2003 | 981 | 0.030 |
Why?
|
| Tetraethylammonium | 2 | 2004 | 4 | 0.030 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 2 | 2004 | 17 | 0.030 |
Why?
|
| Chromosome Aberrations | 2 | 2007 | 86 | 0.030 |
Why?
|
| Potassium Channel Blockers | 2 | 2004 | 32 | 0.030 |
Why?
|
| Aldosterone | 1 | 1993 | 51 | 0.030 |
Why?
|
| Dirofilaria immitis | 1 | 1993 | 6 | 0.030 |
Why?
|
| Intercellular Junctions | 2 | 1993 | 32 | 0.030 |
Why?
|
| Thy-1 Antigens | 1 | 1993 | 4 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1993 | 32 | 0.030 |
Why?
|
| Potassium | 2 | 2004 | 168 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1993 | 131 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 1993 | 94 | 0.030 |
Why?
|
| Cell Membrane Permeability | 2 | 1993 | 59 | 0.030 |
Why?
|
| Rats | 5 | 2003 | 5300 | 0.030 |
Why?
|
| Polyvinyl Alcohol | 1 | 1992 | 8 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 1993 | 149 | 0.030 |
Why?
|
| Indoles | 1 | 1993 | 146 | 0.030 |
Why?
|
| Stimulation, Chemical | 2 | 1992 | 57 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2003 | 160 | 0.030 |
Why?
|
| Sequence Alignment | 2 | 2004 | 165 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 127 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2003 | 111 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 2003 | 791 | 0.020 |
Why?
|
| Time Factors | 5 | 1993 | 4655 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2003 | 282 | 0.020 |
Why?
|
| Genetic Vectors | 2 | 2002 | 312 | 0.020 |
Why?
|
| Ion Channels | 2 | 1989 | 72 | 0.020 |
Why?
|
| Keratins | 2 | 1988 | 48 | 0.020 |
Why?
|
| Immunoblotting | 3 | 1999 | 254 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 700 | 0.020 |
Why?
|
| Cell Differentiation | 4 | 1999 | 1034 | 0.020 |
Why?
|
| Electrolytes | 1 | 1989 | 47 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1999 | 1083 | 0.020 |
Why?
|
| DNA, Neoplasm | 2 | 2002 | 95 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2002 | 954 | 0.020 |
Why?
|
| Salivary Glands, Minor | 1 | 1989 | 7 | 0.020 |
Why?
|
| Electric Conductivity | 2 | 2004 | 87 | 0.020 |
Why?
|
| Osmolar Concentration | 2 | 2004 | 134 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2002 | 710 | 0.020 |
Why?
|
| Intestines | 1 | 1990 | 114 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 2083 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2012 | 378 | 0.020 |
Why?
|
| Pancreas | 1 | 1990 | 225 | 0.020 |
Why?
|
| Kinetics | 3 | 1996 | 1047 | 0.020 |
Why?
|
| PAX2 Transcription Factor | 1 | 2007 | 11 | 0.020 |
Why?
|
| Action Potentials | 1 | 1989 | 223 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2007 | 54 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1987 | 144 | 0.020 |
Why?
|
| Sublingual Gland | 1 | 1987 | 5 | 0.020 |
Why?
|
| Immune Sera | 1 | 1987 | 30 | 0.020 |
Why?
|
| Ion Exchange | 1 | 1987 | 3 | 0.020 |
Why?
|
| Anions | 1 | 1987 | 12 | 0.020 |
Why?
|
| Parotid Gland | 1 | 1987 | 33 | 0.020 |
Why?
|
| Regression Analysis | 3 | 1994 | 737 | 0.020 |
Why?
|
| Biomarkers | 1 | 1993 | 1593 | 0.020 |
Why?
|
| Apocrine Glands | 1 | 1986 | 1 | 0.020 |
Why?
|
| Eccrine Glands | 1 | 1986 | 3 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 357 | 0.020 |
Why?
|
| Acetylgalactosamine | 1 | 1986 | 10 | 0.020 |
Why?
|
| Sebaceous Glands | 1 | 1986 | 8 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2012 | 596 | 0.020 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1987 | 46 | 0.020 |
Why?
|
| Lectins | 1 | 1986 | 81 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1987 | 137 | 0.020 |
Why?
|
| Endothelium | 1 | 1986 | 98 | 0.020 |
Why?
|
| Epidermis | 1 | 1986 | 42 | 0.020 |
Why?
|
| Adolescent | 4 | 1998 | 8912 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 1987 | 155 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 1986 | 75 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1986 | 238 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 2 | 1994 | 74 | 0.020 |
Why?
|
| Nifedipine | 1 | 2004 | 40 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 1118 | 0.010 |
Why?
|
| Drug Interactions | 2 | 1996 | 289 | 0.010 |
Why?
|
| Collagen | 2 | 2003 | 636 | 0.010 |
Why?
|
| Malpighian Tubules | 1 | 2003 | 2 | 0.010 |
Why?
|
| Salt Gland | 1 | 2003 | 8 | 0.010 |
Why?
|
| Antigens, Neoplasm | 2 | 1994 | 132 | 0.010 |
Why?
|
| Cations | 1 | 2004 | 51 | 0.010 |
Why?
|
| Insecta | 1 | 2003 | 11 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2004 | 86 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 204 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 138 | 0.010 |
Why?
|
| Fibroblasts | 2 | 2003 | 902 | 0.010 |
Why?
|
| Sharks | 1 | 2003 | 15 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2003 | 22 | 0.010 |
Why?
|
| Mammary Glands, Human | 1 | 2003 | 33 | 0.010 |
Why?
|
| Cell Nucleus | 2 | 1998 | 305 | 0.010 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2003 | 6 | 0.010 |
Why?
|
| APOBEC-1 Deaminase | 1 | 2003 | 6 | 0.010 |
Why?
|
| Inulin | 2 | 1993 | 5 | 0.010 |
Why?
|
| Basement Membrane | 1 | 2003 | 48 | 0.010 |
Why?
|
| Streptozocin | 1 | 2003 | 34 | 0.010 |
Why?
|
| Cytidine Deaminase | 1 | 2003 | 17 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 194 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2002 | 17 | 0.010 |
Why?
|
| Colforsin | 2 | 1993 | 42 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2003 | 72 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2002 | 2689 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 233 | 0.010 |
Why?
|
| Proline | 1 | 2002 | 52 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 1851 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 60 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 2002 | 53 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 105 | 0.010 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 137 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2002 | 24 | 0.010 |
Why?
|
| G-Protein-Coupled Receptor Kinase 4 | 1 | 2002 | 4 | 0.010 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2002 | 76 | 0.010 |
Why?
|
| Cyclins | 1 | 2002 | 50 | 0.010 |
Why?
|
| Albuminuria | 1 | 2003 | 171 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2002 | 114 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 295 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 161 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2002 | 97 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 262 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2003 | 186 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 258 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 242 | 0.010 |
Why?
|
| Homeostasis | 1 | 2003 | 291 | 0.010 |
Why?
|
| Lipids | 1 | 2003 | 298 | 0.010 |
Why?
|
| Transgenes | 1 | 2001 | 92 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 2001 | 81 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 62 | 0.010 |
Why?
|
| Aged | 3 | 1999 | 14862 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 455 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 782 | 0.010 |
Why?
|
| Fibrosis | 1 | 2002 | 371 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 742 | 0.010 |
Why?
|
| Cell Line | 2 | 1996 | 1752 | 0.010 |
Why?
|
| Culture Media | 2 | 1992 | 155 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2002 | 432 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 554 | 0.010 |
Why?
|
| Heart Rate | 1 | 2002 | 568 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 489 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 800 | 0.010 |
Why?
|
| Urodela | 1 | 1999 | 31 | 0.010 |
Why?
|
| Receptors, Parathyroid Hormone | 1 | 1999 | 1 | 0.010 |
Why?
|
| beta-Adrenergic Receptor Kinases | 1 | 1999 | 7 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 100 | 0.010 |
Why?
|
| cis-trans-Isomerases | 1 | 1999 | 63 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 1999 | 36 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1999 | 49 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 1033 | 0.010 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 1999 | 17 | 0.010 |
Why?
|
| COS Cells | 1 | 1999 | 155 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 947 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 231 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 251 | 0.010 |
Why?
|
| Type C Phospholipases | 1 | 1999 | 67 | 0.010 |
Why?
|
| Karyotyping | 1 | 1998 | 74 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 25 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2001 | 291 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1998 | 18 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 95 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 31 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 93 | 0.010 |
Why?
|
| Mutation | 2 | 1994 | 1213 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 181 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2003 | 1692 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 144 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 475 | 0.010 |
Why?
|
| Eye Proteins | 1 | 1999 | 160 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 245 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 67 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 1996 | 24 | 0.010 |
Why?
|
| Thymidine | 1 | 1996 | 32 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1996 | 109 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1999 | 1200 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1996 | 110 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2002 | 1451 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 163 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2550 | 0.010 |
Why?
|
| Antibodies | 1 | 1996 | 241 | 0.010 |
Why?
|
| Receptors, Somatomedin | 1 | 1994 | 7 | 0.010 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 1994 | 14 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 1996 | 211 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1994 | 119 | 0.010 |
Why?
|
| WT1 Proteins | 1 | 1993 | 5 | 0.010 |
Why?
|
| Prognosis | 1 | 1999 | 2093 | 0.010 |
Why?
|
| Genotype | 1 | 1996 | 786 | 0.010 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1993 | 41 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1993 | 7 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1993 | 159 | 0.010 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1993 | 52 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1993 | 93 | 0.010 |
Why?
|
| Leucine | 1 | 1993 | 41 | 0.010 |
Why?
|
| Ouabain | 1 | 1993 | 32 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 30 | 0.010 |
Why?
|
| Receptors, Angiotensin | 1 | 1993 | 59 | 0.010 |
Why?
|
| p-Aminohippuric Acid | 1 | 1993 | 3 | 0.010 |
Why?
|
| Folic Acid Antagonists | 1 | 1992 | 20 | 0.010 |
Why?
|
| Tritium | 1 | 1992 | 101 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1993 | 260 | 0.010 |
Why?
|
| Cell Count | 1 | 1993 | 248 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1993 | 150 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1993 | 117 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 1993 | 301 | 0.010 |
Why?
|
| Methotrexate | 1 | 1992 | 91 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1992 | 24 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 261 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 381 | 0.010 |
Why?
|
| Sodium | 1 | 1992 | 161 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1993 | 682 | 0.010 |
Why?
|
| Muridae | 1 | 1990 | 9 | 0.010 |
Why?
|
| Genitalia, Male | 1 | 1990 | 14 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1990 | 124 | 0.010 |
Why?
|
| Muscles | 1 | 1990 | 158 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1990 | 282 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1993 | 689 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 1989 | 54 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1992 | 307 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1990 | 221 | 0.000 |
Why?
|
| Blood | 1 | 1988 | 40 | 0.000 |
Why?
|
| Streptomycin | 1 | 1988 | 12 | 0.000 |
Why?
|
| Desmosomes | 1 | 1988 | 14 | 0.000 |
Why?
|
| Organoids | 1 | 1988 | 42 | 0.000 |
Why?
|
| Laminin | 1 | 1988 | 62 | 0.000 |
Why?
|
| Lung | 1 | 1990 | 849 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1990 | 2791 | 0.000 |
Why?
|